PA
HLMN icon

PharVision Advisers’s Hillman Solutions HLMN Stock Holding History

PharVision Advisers’s Portfolio HLMN Stock Details HLMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,413
Closed -$345K – 384
2024
Q4 		$345K Buy
+35,413
New +$379K 0.29% 110

Other funds holding HLMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PharVision Advisers's HLMN Position: Q1 2025 in Review

PharVision Advisers sold out of Hillman Solutions (HLMN) in Q1 2025, closing a stake of 35,413 shares — an estimated $345K sold.

PharVision Advisers first reported a position in HLMN in Q4 2024 and held it in 1 quarter. The position peaked at $345K in Q4 2024. 245 funds tracked by Wall St. Rank hold HLMN as of Q1 2025.

  • PharVision Advisers reported no remaining Hillman Solutions position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 35,413 Hillman Solutions shares in Q1 2025, an estimated $345K.
  • PharVision Advisers first reported a position in Hillman Solutions in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Hillman Solutions position peaked at $345K in Q4 2024.
  • 245 funds tracked by Wall St. Rank held Hillman Solutions as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.